News

Eudaemon Awarded $4m MDF Funding To Develop And Commercialise Next Generation Condom

Eudaemon Awarded $4m MDF Funding To Develop And Commercialise Next Generation Condom

Eudaemon Technologies has received $4m in funding from the NSW Medical Devices Fund (MDF) to continue the development and commercialisation of its next generation hydrogel condom.
Read More
Eudaemon Receives $1.5m MRFF Funding Award To Advance Next Generation Condom Project

Eudaemon Receives $1.5m MRFF Funding Award To Advance Next Generation Condom Project

Eudaemon Technologies have been awarded $1.5m in funding to advance the clinical trial of their next generation condom project, awarded by the Medical Research Future Fund (MRFF) funding from the Australian Government’s Clinical Translation and Commercialisation Medtech (CTCM) program, delivered by MTPConnect.
Read More
Beyond The Medicine Cabinet Podcast - The Technology That Has The Sex Industry Covered - Safely!

Beyond The Medicine Cabinet Podcast - The Technology That Has The Sex Industry Covered - Safely!

When it comes to preventing sexually transmitted infections there are limited options. And the options we do have - condoms - lack desirability, so much so that most of us avoid using them. Revolutionising the condom for the first time in over 100 years is Eudaemon Technologies. Their tech, Gel-dom, is turning a ‘need to’ into a ‘want to’ which could have a major impact on the rates of STIs and unintended pregnancies.
Read More
Eudaemon Shares Their Innovation Journey At The Hall & Wilcox Tech Week 2022

Eudaemon Shares Their Innovation Journey At The Hall & Wilcox Tech Week 2022

Nick Northcott, Co-Founder & Executive Chairman of Eudaemon Technologies spoke at the Hall & Wilcox’s inaugural Tech Week 2022 conference about using technology to solve problems and the role leaders can play in driving change through innovative thinking and collaboration.
Read More
Why Biotech Investors Need A Research Ombudsman

Why Biotech Investors Need A Research Ombudsman

Digital health and biotech investors are being left in the dark about the quality of research emerging from local health sciences companies and academic institutes, according to Executive Chairman, Nick Northcott. Read the full article by Yolanda Redrup published in The Australian Financial Review and insights from Nick to find out more about why biotech investors need a research ombudsman.
Read More
Eudaemon Works On Priority Research Projects Supported By The REDI Fellowship Program

Eudaemon Works On Priority Research Projects Supported By The REDI Fellowship Program

Eudaemon Technologies is privileged to work with Associate Professor Gianni Rendais, the Department Chair of Architectural and Industrial Design at Swinburne University of Technology who have secured sought-after industry placements under the REDI (Researcher Exchange and Development within Industry) Fellowship program to develop a User Centred Design & Medical Device Development pathway to help facilitate design-driven translational outcomes from fundamental research.
Read More
Eudaemon Featured In Rolling Stone Better, Safer Sex: On The Hunt For A Condom People Will Actually Like

Eudaemon Featured In Rolling Stone Better, Safer Sex: On The Hunt For A Condom People Will Actually Like

When biomedical engineer Robert Gorkin saw the Bill and Melinda Gates Foundation’s 2013 call for submissions for a next-generation condom, he was hardly a contraceptive innovator. Rather, his work focused on 3D-printing organs and prosthetics.

Read More
Next-Generation Condom Secures $1 Million Government Funding

Next-Generation Condom Secures $1 Million Government Funding

A next-generation hydrogel condom developed with Swinburne research has secured a $1 million NSW Medical Devices Fund (MDF) grant that will help to fund manufacturing and human trials in late 2018.

Read More